Quince (Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-derived macrophages through NF-κB, p38MAPK and Akt inhibition

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 180-185

  Essafi Benkhadir, Khadija ^a   Refai, Amira ^a   Riahi, Ichrak ^a   Fattouch, Sami ^b   Karoui, Habib ^a   Essafi, Makram ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF CARTHAGE   (Tunisia)

Author keywords

Cytokines; Inflammation; Macrophages; Polyphenols; Quince; Signalling pathways

Indexed keywords

ANTIINFLAMMATORY AGENT; CYDONIA OBLONGA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 14; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; QUINCE; TRANSCRIPTION REGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-AKT; ROSACEAE; TUMOR NECROSIS FACTOR-ALPHA;

CYDONIA OBLONGA;

EID: 84856433514     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.003     Document Type: Article

References (43)

1. Zarubin T., Han J. Activation and signaling of the p38MAP kinase pathway. Cell. Res. 2005, 15:11-18.
2. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J.G., Baldwin A.S., Mayo1 M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell. Biol. 2000, 20:1626-1638.
3. S.W. Tas, P.H. Remans, K.A. Reedquist, P.P. Tak, Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy, Curr. Pharm. Des. (2005) 581-611.
4. Ito K., Caramori G., Adcock I.M. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J. Pharmacol. Exp. Ther. 2007, 321:1-8.
5. Mewar D., Wilson A.G. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br. J. Phamacol. 2011, 162:785-791.
6. Yong H.Y., Koh M.S., Moon A. The p38MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert. Opin. Invest. Drugs 2009, 18:1893-1905.
7. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
8. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Mitchell J.A., Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 1999, 96:7563-7568.
9. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79:727-747.
10. Kang N.J., Shin S.H., Lee H.J., Lee K.W. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol. Ther. 2011, 130:310-324.
11. Kim D.O., Lee K.W., Lee H.J., Lee C.Y. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. J. Agric. Food. Chem. 2002, 50:3713-3717.
12. Eberhardt M.V., Lee C.Y., Liu R.H. Antioxidant activity of fresh apples. Nature 2000, 405:903-904.
13. Korycka-Dahl M.B., Richardson T. Activated oxygen species and oxidation of food constituents, CRC. Crit. Rev. Food. Sci. Nutr. 1978, 10:209-241.
14. Lavelli V., Hippeli S., Peri C., Elstner E.F. Evaluation of radical scavenging activity of fresh and air-dried tomatoes by three model reactions. J. Agri. Food. Chem. 1999, 47:3826-3831.
15. Fattouch S., Caboni P., Coroneo V., Tuberoso C.I., Angiono A., Dessi S., Marzouki N., Cabras P. Antimicrobial activity of Tunisian quince (Cydonia oblonga Miller) pulp and peelpolyphenolicextracts. J. Agric. Food. Chem. 2007, 55:963-969.
16. Laskin D.L., Sunil V.R., Gardner C.R., Laskin J.D. Macrophages and tissue injury: agents of defense or destruction?. Annu. Rev. Pharmacol. Toxicol. 2011, 51:267-288.
17. Daigneault M., Preston J.A., Mariott H.M., Whyte M.K., Dockrell D.H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One 2010, 5:e8668.
18. Singh U., Tabibian J., Venugopal S.K., Devaraj S., Jialal I. Development of an in vitro screening assay to test the anti-inflammatory properties of dietary supplements and pharmacologic agents. Clin. Chem. 2005, 51:2256.
19. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. 1997, 2:d12-d26.
20. Huber A.R., Kundel S.L., Todd R.F. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254:99-102.
21. Rosenblum H., Amital H. Anti-TNF therapy: safety aspects of taking the risk. Autoimmun. Rev. 2011, 10:563-568.
22. Warner T.D., Giualiano F., Vojnovic I., Bukasa A., Mitchell J.A., Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 1999, 96:7563-7568.
23. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
24. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Ex. Med. 1991, 174:1209-1220.
25. Friedrich M., Döcke W.D., Klein A., Philipp S., Volk H.D., Sterry W., Asadullah K. Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis. J. Invest. Dermatol. 2002, 118:672-677.
26. F.E. Buruiana, I. Solà, P. Alonso-Coello, Recombinant human interleukin-10 for induction of remission in Crohn's disease, Cochrane, Database. Syst. Rev. 11 (2010) CD005109.
27. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin. Immunol. Immunopathol. 1992, 62:S60-S65.
28. Tan P.L., Farmiloe S., Yeoman S., Watson J.D. Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts. J. Rheumatol. 1990, 17:1608-1612.
29. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S.C., Dinarello C.A. Correlations and interactions in the production of interleukin-6, IL-1, and tumor necrosis factor in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990, 75:40-47.
30. Starkie R., Ostrowiski S.R., Jauffred S., Febbraio M., Pedersen B.K. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003, 17:884-886.
31. Baldwin A.S. The NF-kappaB and I kappa-B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
32. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109:S81-S96.
33. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
34. Hwang D., Jang B.C., Yu G., Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem. Pharmacol. 1997, 54:87-96.
35. Monick M.M., Carter A.B., Flaherty D.M., Peterson M.W., Hunninghake G.W. Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J. Immunol. 2000, 165:4632-4639.
36. Monick M.M., Carter A.B., Robeff P.K., Flaherty D.M., Peterson M.W., Hunninghake G.W. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 2001, 166:4713-4720.
37. Koul S.A., Chopra K., Rishi P. Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One 2011, 6:e20635.
38. Nones K., Dommels Y.E., Martell S., et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br. J. Nutr. 2009, 101:169-181.
39. Han Y. Rutin has therapeutic effect on septic arthritis caused by Candida albicans. Int. Immunopharmacol. 2009, 9:207-211.
40. Lee S., Park H.S., Notsu Y., et al. Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide-induced nitrite production in rat peritoneal macrophages. Phytother. Res. 2008, 22:1552-1556.
41. Terra X., Palozza P., Fernandez-Larrea J., et al. Procyanidin dimer B1 and trimer C1 impair inflammatory response signalling in human monocytes. Free Radic. Res. 2011, 45:611-619.
42. Chagas-Paula D.A., Oliveira R.B., da Silva V.C., et al. Chlorogenic acids from Tithonia diversifolia demonstrate better anti-inflammatory effect than indomethacin and its sesquiterpene lactones. J. Ethnopharmacol. 2011, 136:355-362.
43. Gong J.H., Shin D., Han S.Y., Kim J.L., Kang Y.H. Kaempferol suppresses eosinophil infiltration and airway inflammation in airway epithelial cells and in mice with allergic asthma. J. Nutr. 2012, 142:47-56.